Summit Therapeutics
Price & Volume
Stats
See more52W Range | $13.83-$36.91 |
Market Cap | $12B |
Shares Short | 34M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $705,000 |
Diluted EPS | -$1.44 |
News
See moreYahoo Finance • 23 days ago
Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab
Yahoo Finance • 29 days ago
Summit Therapeutics plans interim PFS analysis for HARMONi-3 squamous cohort in Q2 2026 as clinical pipeline expands
Yahoo Finance • 30 days ago
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025
Yahoo Finance • last month
Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough
About
CEO | Mr. Robert W. Duggan |
CFO | Mr. Manmeet Singh Soni CPA |
Address | 601 Brickell Key Drive, Miami, FL, United States, 33131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 265 |
